Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) - Wikidata - awgldk - TriplyDB

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

http://www.wikidata.org/entity/Q58125280

about

Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan Amyotrophic lateral sclerosis and environmental factors A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis Potential Environmental Factors in Amyotrophic Lateral Sclerosis Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis.Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Moderate exercise delays the motor performance decline in a transgenic model of ALS.Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence.Prognostic factors for the course of functional status of patients with ALS: a systematic review.Amyotrophic lateral sclerosis and agricultural environments: a systematic review.A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives.Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis.A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.Smoking may be considered an established risk factor for sporadic ALS.Neurodegenerative disorders and nanoformulated drug development.Are professional soccer players at higher risk for ALS?Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients.Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.Pesticides: an update of human exposure and toxicity.Disease progression and survival in ALS: first multi-state model approach.RandomForest4Life: a Random Forest for predicting ALS disease progression.Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival.ALS disease onset may occur later in patients with pre-morbid diabetes mellitus.Monitoring respiratory muscle strength assists in early diagnosis of respiratory dysfunction as opposed to the isolated use of pulmonary function evaluation in amyotrophic lateral sclerosis.Are statin medications safe in patients with ALS?Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study.A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN.Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975 - 2004.Does apolipoprotein E genotype modify the clinical expression of ALS?Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry

P2860

Q23915088-9765E723-2029-4FF7-AFD4-67E96D04C0DC Q23924099-821BC36A-9837-4E27-83A3-3984F707A051 Q26749342-79430310-46E4-47A3-80BD-30BAD6CFF1C2 Q28383030-76A3A1A9-1638-4556-96EF-A3073D797C03 Q28393938-DFB3A14D-1383-48A1-9AE0-CFDBFAF0EA08 Q28395854-944FD3F1-83E0-4731-905D-E44684FF1B5F Q28649394-CC9F4C25-2961-44A1-88FA-A74A15A7D5D4 Q30365956-DCBCB9DC-7F2D-43EC-82B3-0E9209523085 Q30866592-88869C73-E234-41F9-8BC9-E948E1ABFE4D Q33508809-39CE6ACB-C369-43F8-B75E-788DA15A1B74 Q33726019-35AA1E42-DFA3-441F-8320-A79D0EFCC143 Q33943887-1833F2D2-8E8A-40F9-A6C4-7A0E9C0E5887 Q34016411-936D9EEC-D759-4F40-9DFE-DA6B1945C995 Q34447158-07B11E43-65E0-4DD2-925A-CBE888206925 Q34591885-325042AD-CF1D-4E01-ACF3-1D4578C7860A Q36311348-5DE677A6-932D-4ED6-AE0D-912AD7790B76 Q37063910-073C62F2-A182-4345-BEF8-8BE484D6E2F3 Q37107393-9FA33BA4-A8BC-4691-B20E-5C5D6F80DE38 Q37139024-C66D4A40-4669-4BBA-88CC-D510E1C44549 Q37209744-AEC38C3B-E4C5-4ADF-961B-2344943E964F Q37253741-8C33CD5B-A71F-4B25-8AD0-C697B5D8F494 Q37386444-AA8B22CA-54F7-4A3A-A540-41BD2CA0A0C8 Q37459710-6FC5E0C0-1058-40DA-BD43-F89EF852A6D5 Q37538771-5777CDCD-6D4C-43B0-9BB5-43E1A0C3F0F8 Q38121959-21CB6813-E98F-48CC-8523-61B19A871FCF Q38196863-B65733BA-2512-4D21-9F74-76D7953445CB Q38258651-ECE0A31D-6311-45F5-B20C-A2480E96E79D Q38272668-10E52316-8A46-4A81-B6A7-FACAC9C67BE9 Q38976967-BA5C8BD5-EB3C-4794-8D3F-EC85B17976EB Q39023321-07389DB5-8127-431C-95C7-5CB3925662E4 Q39142484-B87A13B8-0019-458F-A54E-7EC8E5A8F198 Q42706766-36C1D52F-220A-480E-BDD9-81B4E303ABF6 Q43504933-80DF13F6-9CDA-4FAB-B0C2-04552A3F4191 Q43701400-8D473856-C592-4AD3-AAAA-9533C87A67CB Q46496531-BDC8C3C2-BC7B-4CA4-B35F-4F2A5F687977 Q47801029-952760AE-7968-4460-BACB-946C0D16B668 Q48266568-AD02767D-CEEA-4CEA-9B41-3D77B92ACB47 Q51726897-C7C270B3-DAC7-409B-9FA0-40FE04D82AAD Q54408959-346D2C6D-0A5A-4C21-9683-DDCD4581F264 Q56839376-1CF33F4A-28A2-4AF1-927C-A45ED3B01B1D

P2860

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS)

http://www.wikidata.org/entity/Q58125280

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в січні 2006

@uk

name

Analysis of factors that modif ...... rophic lateral sclerosis (ALS)

@en

Analysis of factors that modif ...... amyotrophic lateral sclerosis

@nl

type

label

Analysis of factors that modif ...... rophic lateral sclerosis (ALS)

@en

Analysis of factors that modif ...... amyotrophic lateral sclerosis

@nl

prefLabel

Analysis of factors that modif ...... rophic lateral sclerosis (ALS)

@en

Analysis of factors that modif ...... amyotrophic lateral sclerosis

@nl

P1433

Q58125280-87B4DE61-AC1C-4026-8761-87621C439320

P1476

Q58125280-0F0550AE-E784-4709-A23A-F6F67EF7F676

P2093

Q58125280-0386D1CE-7672-4F7C-9E53-AB4D91960DCF

Q58125280-2BA2CA6D-FC0E-409B-AD76-07383113C7C5

Q58125280-3A04B830-75EF-4AD9-B0ED-EB78EA84F743

Q58125280-4A4CEF7C-A328-4281-864C-C92F45E803CA

Q58125280-4F255F38-BC3C-4176-B862-EEB2F8157EFF

Q58125280-A6370BBD-4CFE-4BCA-9EF8-CF3DA7A43DD2

Q58125280-F3A3DB5C-E645-4E78-8338-B126EDF1A2A6

P2860

Q58125280-0251DAB4-C099-4B0F-98F1-48DB14223E9F

Q58125280-03DC04A8-0113-4F4D-944D-0B3AFD735364

Q58125280-06406C25-04CB-4E56-87A9-1613E33A7CAF

Q58125280-110DD72A-BE49-4822-9CE2-DCCED374C956

Q58125280-19105C93-F100-4780-A47D-EC24C12854C9

Q58125280-19F73F14-DF46-4F08-9F4A-F51868B350EE

Q58125280-1CAE719F-7E33-4402-A44A-9AEAFB3329EF

Q58125280-1CC8998B-5F29-442A-A95D-969BCB6EEA1E

Q58125280-1D9D9754-086D-4B82-979C-167EFC263B14

Q58125280-22372924-785B-4C1A-9A35-B293E15EF7F0

P304

Q58125280-440DE1EE-9DC1-46DF-B43E-8F187C84CDF6

P31

Q58125280-E4819CA0-6188-4427-A5E2-49C36D6C3748

P356

Q58125280-D091EB05-BB73-4DA8-A4BB-7193576384FF

P433

Q58125280-ED8FCABA-E823-4DB3-81F3-76CE1389E705

P478

Q58125280-B529EEC9-D772-41DF-B5EF-A165BA4CE4BA

P50

Q58125280-2EA15255-1308-4D85-B41F-BF15A5CBC27E

Q58125280-512444ED-C2EC-412C-8FDB-E51D1BCCCFB9

Q58125280-885E461F-BD85-46AC-9918-5D0D60251C04

P577

Q58125280-8AD5151B-091C-4F49-82E6-389CB16F3851

P698

Q58125280-03083F64-5FCE-4229-8D4E-AFDFA86F17AB

P921

Q58125280-91E633E7-D8DC-4F20-868C-70F9180D7F7C

P356

14660820600640596

P1433

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

P1476

Analysis of factors that modif ...... rophic lateral sclerosis (ALS)

@en

P2093

Daniela Myers

http://www.w3.org/2001/XMLSchema#string

Douglas Hayden

http://www.w3.org/2001/XMLSchema#string

Kristyn Newhall

http://www.w3.org/2001/XMLSchema#string

Leo Urbinelli

http://www.w3.org/2001/XMLSchema#string

M Muddasir Qureshi

http://www.w3.org/2001/XMLSchema#string

Ryan Smart

http://www.w3.org/2001/XMLSchema#string

Sarah Hilgenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Amyotrophic lateral sclerosis, lead, and genetic susceptibility: polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS

Unraveling the mechanisms involved in motor neuron degeneration in ALS

Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based case-control study.

Environmental risk factors for amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis: toxins and environment.

An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis.

Polymorphisms of toxifying and detoxifying hepatic enzymes in amyotrophic lateral sclerosis.

Occurrence of amyotrophic lateral sclerosis among Gulf War veterans.

P304

173-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14660820600640596

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly Ferrante

Merit E Cudkowicz

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16963407

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis